Studies have reported a low mRNA expression of TGF-β1 at the mRNA level in the early inflammatory response in upper airway samples [33] or no elevated concentration of TGF-β1 in blood samples at diagnosis of COVID-19 by PCR suggesting no help to anticipate long-term prognosis [254]. Here, TGFB1 is linked to COVID-19.